Home LiteratureArticle Details
PMID: 1330614 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Suramin: a selective inhibitor of purinergic neurotransmission in the rat isolated vas deferens.

European journal of pharmacology ·Vol. 220 ·No. 1 ·1992-09-10 ·Pages 1-10

Mallard N, Marshall R, Sithers A, Spriggs B

Abstract

The effects of the putative P2 purinoceptor antagonist suramin on contractile responses of the rat isolated vas deferens to electrical field stimulation and exogenously applied drugs (alpha,beta-methylene ATP and noradrenaline) were investigated. Suramin was devoid of agonist activity in the rat vas deferens. The response of the vas deferens to single pulse field stimulation was characteristically biphasic with a large first component peaking between 260-300 ms after the stimulus followed by a second smaller component peaking at about 650 ms post-stimulus. Suramin (100 nM-1 mM) selectively impaired the first, purinergic phase of the response to single pulse field stimulation but was without effect on the second, noradrenergic component. The response of the vas deferens to trains of electrical field stimuli (10 Hz for 10 s) was also biphasic. Suramin (1 microM-1 mM) reduced the first (less than 1 s) phase of the response by 30%, the second (greater than 5 s) plateau phase by 50% and inhibited the intermediate (2-4 s) phase by 80%. Dose-contact periods of 20 or 30 min respectively were sufficient to achieve equilibration of the inhibitory effects of suramin against the responses to single pulse field stimulation or trains of pulses. Following 30 min incubation with 1 mM suramin, the remaining first and second phase components of the response to trains of pulses were impaired and subsequently abolished by the alpha 1-adrenoceptor antagonist WB4101 establishing their noradrenergic origin. Suramin (300 microM) abolished responses of the vas deferens to alpha,beta-methylene ATP but was without effect on those to noradrenaline. Suramin (30 microM) induced a rightward shift in the concentration-response relationship to alpha,beta-methylene ATP that was associated with a significant 40% increase in the maximum response, but did not modify responses to noradrenaline. The inhibitory effects of suramin (3-300 microM) on responses of the vas deferens to approximate EC50 concentrations of alpha,beta-methylene ATP were reversible on repeated washout for 40-60 min. These results reveal suramin to be a useful pharmacological tool for the study of purinergic neurotransmission in rodent vasa deferentia.

MeSH Terms
Adenosine Triphosphate/analogs & derivatives,pharmacology Animals Electric Stimulation In Vitro Techniques Male Muscle Contraction/drug effects Nifedipine/pharmacology Norepinephrine/pharmacology Purinergic Antagonists Rats Rats, Wistar Suramin/pharmacology Synaptic Transmission/drug effects Vas Deferens/drug effects,innervation
Chemicals
Purinergic Antagonists Suramin Adenosine Triphosphate Nifedipine alpha,beta-methyleneadenosine 5'-triphosphate Norepinephrine
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Mallard N
Department of Pharmacology and Therapeutics, University of Wales College of Medicine, Heath Park, Cardiff, South Glamorgan, UK.
Marshall R
Sithers A
Spriggs B
Article Info
Journal
European journal of pharmacology
Abbr.
Eur J Pharmacol
ISSN
0014-2999
Published
1992-09-10
Pages
1-10
Language
English
Region
Netherlands
NLM ID
1254354
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com